These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8140661)

  • 1. [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group].
    Reimers JI; Andersen HU; Pociot F
    Ugeskr Laeger; 1994 Jan; 156(4):461-5. PubMed ID: 8140661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide.
    Gale EA
    Horm Res; 1996; 45 Suppl 1():39-43. PubMed ID: 8805029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevention of insulin-dependent diabetes mellitus].
    Loureiro MM; Duarte R; Boavida JM; Lisboa PE
    Acta Med Port; 1996; 9(10-12):353-60. PubMed ID: 9254534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of type 1 diabetes: from the view point of beta cell damage.
    Kawasaki E; Abiru N; Eguchi K
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S27-32. PubMed ID: 15563975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide in type 1 diabetes. Mechanism of action revisited.
    Kolb H; Burkart V
    Diabetes Care; 1999 Mar; 22 Suppl 2():B16-20. PubMed ID: 10097894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
    Rabinovitch A; Suarez WL; Power RF
    J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interleukin-1 and nitric oxide involved in the pathogenesis of diabetes)].
    Sjöholm A
    Lakartidningen; 1999 May; 96(19):2338-41. PubMed ID: 10377681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of type 1a diabetes mellitus*.
    Wilson DM; Buckingham B
    Pediatr Diabetes; 2001 Mar; 2(1):17-24. PubMed ID: 15016206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for preventing type I diabetes mellitus.
    Verge CF; Eisenbarth GS
    West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial].
    Undlien DE; Joner G; Dahl-Jørgensen K; Rønningen KS; Nicol-Smith L; Torjesen PA; Søvik O
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2799-803. PubMed ID: 11107929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.